The introduction of Retatrutide ZPHC, at a strength of 120mg, is sparking considerable excitement within the medical community. This groundbreaking dual GIP and GLP-1 target medication suggests to offer impressive improvements in weight loss compared to existing therapies. Preliminary research studies have indicated significant decreases in body fa